The use of quaternary narcotic antagonists in opiate research
- 1 March 1985
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 24 (3), 181-191
- https://doi.org/10.1016/0028-3908(85)90072-3
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health
- National Institutes of Health (GM-22220)
This publication has 43 references indexed in Scilit:
- Effects of naltrexone on plasma corticosterone in opiate-naive rats: A central actionLife Sciences, 1984
- Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compoundsLife Sciences, 1983
- Quaternary derivatives of narcotic antagonists: Stereochemical requirements at the chiral nitrogen for in vitro and in vivo activityLife Sciences, 1983
- Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonistsLife Sciences, 1983
- Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrierLife Sciences, 1983
- Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonistLife Sciences, 1982
- Effects of N-methylnaloxone and N-methylanaltrexone on nociception and precipitated abstinence in miceLife Sciences, 1982
- Inhibition of inflammatory pain by naloxone and its N methyl quaternary analogueLife Sciences, 1982
- Peripheral antinociceptive effects of N-methyl morphineLife Sciences, 1982
- The possible role of intracellular receptors in the expression of narcotic antagonist precipitated abstinenceLife Sciences, 1981